U.S. stock indices slump amid tariff talks while healthcare sees major developments: J&J faces a $1.6B lawsuit, new FDA approvals, and a $2B ...

The health sector faces challenges as Novo Nordisk's sales projections dim, Johnson & Johnson's unit faces hefty fines, and ...

Janssen Products LP must pay over $1.6 billion in a False Claims Act suit for improperly billing the US government for HIV ...

The FDA recently approved the first treatment in nearly 30 years for acute stroke, and the agency also approved a novel drug ...

Tariffs drive inflation, negatively impacting consumers on both sides of the Atlantic. Increased protectionism is in nobody’s ...

India with its vast pharmaceutical and chemical industries is an emerging source for fentanyl precursor chemicals. Mexican ...

The Belgian pharmaceutical company Janssen is currently running a phase I trial of long ... Aqueous nanoparticle suspensions ...

PARP7 is a mono-ADP-ribosyl transferase (mono-ART) which has recently gained attention due to its emerging role as a negative ...

Use precise geolocation data. Actively scan device characteristics for identification. Store and/or access information on a ...

Despite advances in anticoagulant therapies, bleeding remains a critical concern.Traditionally, the definition of major ...